Results 11 to 20 of about 13,126,675 (165)

Liposomal amphotericin B and leishmaniasis: Dose and response

Journal of Global Infectious Diseases, 2010
Liposomal amphotericin B has been used with increasing frequency to treat visceral leishmaniasis (VL). It is the treatment of choice for immunocompetent patients in the Mediterranean region and the preferred drug for HIV/VL co-infection.
Shyam Sundar, Jaya Chakravarty
doaj   +4 more sources

Methods for particle size reduction of liposomal amphotericin B

Vietnam Journal of Science, Technology and Engineering, 2018
Liposomal amphotericin B were prepared by thin film hydration technique. Particle size was reduced by ultrasonic device and high pressure homogeneous device.
Tuan Quang Nguyen, Van Lam Nguyen, Thai Son Nguyen, Thi Minh Hue Pham   +3 more
doaj   +2 more sources

Successful haploidentical stem cell transplantation with prophylactic administration of liposomal amphotericin B after invasive pulmonary zygomycosis

Medical Mycology Case Reports, 2017
A 54-year-old woman with acute myeloid leukemia (AML) achieved complete remission by induction chemotherapy, but developed zygomycosis after consolidation therapy.
Testuro Ochi, Yuta Katayama, Takeshi Okatani, Ryota Imanaka, Kohei Kyo, Mitsuhiro Itagaki, Shinya Katsutani, Koji Iwato, Hideki Asaoku   +8 more
doaj   +2 more sources

Reversible Ototoxicity: A Rare Adverse Reaction of Liposomal Amphotericin-B Used for the Treatment of Antimony-Resistant Visceral Leishmaniasis in an Elderly Male

Clinical Medicine Insights: Case Reports, 2014
Amphotericin-B, a broad spectrum antifungal agent, has been known to cause adverse effects such as nephrotoxicity and infusion-related side effects such as fever, chills, rigor, and arthralgias. However, ototoxicity as an adverse effect of Amphotericin-B
PC Das, Ramesh Kandel, Kapil Sikka, AB Dey   +3 more
doaj   +2 more sources

Vertebral infection with Candida albicans failing caspofungin and fluconazole combination therapy but successfully treated with high dose liposomal amphotericin B and flucytosine

Medical Mycology Case Reports, 2014
A patient with Candida spondylitis failed two weeks of fluconazole combined with caspofungin, and the infection relapsed despite six weeks of liposomal amphotericin B followed by two months of fluconazole.
Line Storm, Karen R. Lausch, Maiken C. Arendrup, Klaus L. Mortensen, Eskild Petersen   +4 more
doaj   +2 more sources

Lipsosomal amphotericin B: a review of its properties, function, and use for treatment of cutaneous leishmaniasis

Research and Reports in Tropical Medicine, 2019
Mohammad Reza Shirzadi1,21Center for Communicable Diseases Control, Ministry of Health and Medical Education, Tehran, Iran; 2Center for Research of Endemic Parasites of Iran (CREPI), Tehran University of Medical Science, Tehran, IranAbstract: The genus ...
Shirzadi MR
doaj   +1 more source

Liposomal amphotericin B-the present. [PDF]

J Antimicrob Chemother, 2022
Most invasive fungal infections are opportunistic in nature but the epidemiology is constantly changing, with new risk groups being identified. Neutropenia is a classical risk factor for fungal infections, while critically ill patients in the ICU are now
Maertens J, Pagano L, Azoulay E, Warris A.   +3 more
europepmc   +2 more sources

Successful treatment of invasive tracheobronchial pulmonary aspergillosis with venovenous extracorporeal membrane oxygenation and combined systemic, intratracheal instillation of liposomal amphotericin B: a case report

Journal of Medical Case Reports, 2022
Background Invasive pulmonary Aspergillus and invasive bronchial aspergillosis is a life-threatening opportunistic fungal infection that predominantly affects immunocompromised hosts.
Shuku Sato, Wataru Kamata, Kiyomitsu Fukaguchi, Shun Tsunoda, Tadashi Kamio, Hiroshi Koyama, Hideyasu Sugimoto, Yotaro Tamai   +7 more
doaj   +1 more source

Efficacy of aerosolized amphotericin B desoxycholate and liposomal amphotericin B in the treatment of invasive pulmonary aspergillosis in severely immunocompromised rats [PDF]

, 2001
The effects of treatment with aerosolized amphotericin B desoxycholate and aerosolized liposomal amphotericin B were evaluated in severely immunosuppressed rats with invasive pulmonary aspergillosis.
Ruijgrok, E.J. (Elisabeth), Vulto, A.G. (Arnold), Etten, E.W.M. (Els) van, Van Etten, Els W.M., Ruijgrok, Elisabeth J.; id_orcid, Vulto, Arnold G.; id_orcid   +5 more
core   +2 more sources

Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India [PDF]

, 2011
Reports on treatment outcomes of visceral leishmaniasis (VL)-human immunodeficiency virus (HIV) coinfection in India are lacking. To our knowledge, none have studied the efficacy of liposomal amphotericin B in VL-HIV coinfection.
Pece, Manuel, Flevaud, L., Mahajan, Raman, Remartinez, D., Das, Pradeeb, Verma, Neena, Kumar, Nawin, Remartinez, Daniel, M. Pece, Ferreyra, Cecilia, Mitra, G., G. Mitra, N. Verma, Ferreyra, C., Pandey, K., Das, P., van Griensven, Johan, K. Pandey, R. Kumar, R. Mahajan, Mahajan, R., Pandey, Krishna, Kumar, Ranjeet, Mitra, Gaurab, Pece, M., P. P. Palma, Verma, N., P. Das, Kumar, Pankaj, Kumar, N., C. Ferreyra, D. Remartinez, Kumar, P., N. Kumar, Sinha, Prabhat K, Kumar, R., P. K. Sinha, van Griensven, J., Palma, P. P., Sinha, P. K., P. Kumar, Flevaud, Laurence, Palma, Pedro Pablo, J. van Griensven, L. Flevaud   +44 more
core   +1 more source